Showing results (601-610 of 617) with videos related to
Sort By:
Pageof 62
Frontiers in Neurology|July 24, 2023
Prospective collection of blood plasma samples to identify potential biomarkers for the prehospital stroke diagnosis (ProGrEss-Bio): study protocol for a multicenter prospective observational studyFrederik Geisler, Lisa Haacke, Maren Lorenz, et al.International Angiology : a Journal of the International Union of Angiology|March 31, 2010
Chronic cerebrospinal venous insufficiency and iron deposition on susceptibility-weighted imaging in patients with multiple sclerosis: a pilot case-control studyR Zivadinov, C Schirda, M G Dwyer, et al.Neuroimage|June 9, 2026
Membrane and Bioenergetic Dysfunction in Parkinson's Disease with REM Sleep Behavior Disorder: A 31P and 1H MR StudyYan Li, Qiurong Yu, Pei Huang, et al.Nature Communications|February 10, 2026
A catalogue of early diverged contemporary human genome variation reveals distinct Khoe-San populationsWeerachai Jaratlerdsiri, Pamela X Y Soh, Tingting Gong, et al.The EMBO Journal|March 10, 2006
An arginine/lysine-rich motif is crucial for VCP/p97-mediated modulation of ataxin-3 fibrillogenesisAnnett Boeddrich, Sébastien Gaumer, Annette Haacke, et al.Cancers|February 25, 2022
Low Mutational Burden of Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue in Patients with Primary Sjogren's SyndromeJohanna A A Bult, Jessica R Plaça, Erlin A Haacke, et al.Developmental Cell|February 28, 2025
Innate immune training of osteoclastogenesis promotes inflammatory bone loss in miceNora Haacke, Hui Wang, Shu Yan, et al.Journal of Rehabilitation Research and Development|January 28, 2010
Advances in neuroimaging of traumatic brain injury and posttraumatic stress disorderRobert W Van Boven, Greg S Harrington, David B Hackney, et al.Annals of the Rheumatic Diseases|December 15, 2016
Standardisation of labial salivary gland histopathology in clinical trials in primary Sjögren's syndromeBenjamin A Fisher, Roland Jonsson, Troy Daniels, et al.The Lancet. Rheumatology|January 24, 2024
Abatacept treatment for patients with early active primary Sjögren's syndrome: a single-centre, randomised, double-blind, placebo-controlled, phase 3 trial (ASAP-III study)Jolien F van Nimwegen, Esther Mossel, Greetje S van Zuiden, et al.Pageof 62